Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1030220200210040179
Journal of Korean Diabetes
2020 Volume.21 No. 4 p.179 ~ p.183
The Present and Future of Continuous Glucose Monitoring
Jin Sang-Man

Abstract
The accuracy and convenience of real-time continuous glucose monitoring (CGM) devices have been substantially improved in the past decade, with an accuracy comparable to finger-stick glucose meters. In addition, new advantageous features of CGM devices include a painless one button inserter, smaller (or integrated) transmitters, better connectivity with smartphones, an extended 14-day wear period, no acetaminophen interference, and no need for calibration with a finger-stick glucose meter. Real-time CGM is now the go-to diabetes technology for most people with type 1 diabetes, and acts as a gateway to more advanced diabetes technology. Real-time CGM has become a standard therapy for type 1 diabetes, and a well-proven therapy for type 2 diabetes with multiple daily injections. In the near future, advanced hybrid closed-loop devices with an automated correction bolus will be clinically available, which will be a major breakthrough toward fully automated insulin delivery.
KEYWORD
Blood glucose self-monitoring, Diabetes mellitus, type 1, Technology
FullTexts / Linksout information
Listed journal information
KoreaMed